Local antimicrobials in pockets: useful where instrumentation alone was not enough

After correctly performed non-surgical periodontal therapy, some pockets fail to respond. That is the moment, and not before, when the question of a local antimicrobial arises.

The principle is to deliver the drug inside the pocket at concentrations far above anything achievable systemically, without exposing the body to the drug.

The available formulations differ in release kinetics and duration: chlorhexidine chips, doxycycline-based gels, minocycline microspheres, metronidazole gel.

The documented benefit is an additional reduction in probing depth compared with scaling alone, in the order of fractions of a millimetre.

That figure should be reported for what it is: statistically significant in studies, but clinically modest if considered across the whole mouth.

The picture changes once you stop reasoning across the whole mouth. On a single deep site that keeps bleeding, a few tenths of a millimetre and reduced inflammation can be the difference between returning to maintenance and moving to surgery.

The reasonable indication is therefore narrow: isolated sites, residual at reassessment, bleeding on probing, in a patient who is otherwise stable and compliant.

The wrong indication, and the most common one, is use in mouths with widespread plaque and home care that has not yet stabilised. In that context the drug compensates for nothing, and the result vanishes within weeks.

Instrumentation still has to come first. Mature, organised biofilm resists drug penetration in a way that a blade overcomes mechanically and a molecule does not.

Compared with systemic antibiotics the advantage is clear. Those have specific and limited indications, expose the whole organism and contribute to resistance; local release avoids both.

The practical limits are cost per site treated, the need to repeat application in some protocols, and the fact that certain products require the site to be left undisturbed for a period, which has to be explained to the patient.

Before applying anything, one question is worth asking: is that site resisting for anatomical reasons? A root concavity, furcation involvement or a deep vertical defect is not altered by an antimicrobial, and in those cases the drug postpones a decision rather than resolving it.

In summary: local release reaches high concentrations without systemic exposure, the average whole-mouth benefit is modest, it becomes relevant on the single resistant site, instrumentation remains the prerequisite, and on an anatomical defect the antimicrobial postpones the decision rather than resolving it.